Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

real-time data

- PMLiVE

bluebird bio reveals further encouraging data for CALD gene therapy

Study shows continued benefit in treatment of rare disease

- PMLiVE

Takeda’s HAE drug Takhzyro backed by NICE

New treatment option for rare, hereditary disease

- PMLiVE

Distribution of Novartis’ generic Zantac halted due to carcinogen concerns

Ranitidine medicines found to contain cancer-causing substance

Programmatic methodology and why you should be using it

What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director

Four Agency Worldwide

- PMLiVE

When it’s OK to not be OK: Bedrock breaks down mental health stigma

As part of Bedrock’s Wellbeing Programme, Bedrock paired up with Simpila to talk about mental health challenges and open up about the pressures we all face, both in and out...

Bedrock Healthcare Communications

Roche - Basel

Roche wins FDA breakthrough for Gazyva in lupus nephritis

Drug originally approved as a lymphoma treatment

- PMLiVE

Zenopa delivers Communiqué prizes to winners

Publicis Resolute's Georgina Chan, MGP's Peter Sayer and Celgene's Sara Jones win the prizes

Detecting Alzheimer’s ahead of a cure

A focus on promising new research

- PMLiVE

Biogen loses another pipeline drug to toxicity concerns

Follows discontinuation of Eisai-partnered Alzheimer's drug

- PMLiVE

FDA starts speedy review of Merck’s Ebola vaccine

First company to file for approval in the US

Pharma industry consensus: fix data strategy before pushing artificial intelligence and machine learning applications

by Marc Valdiviezo

- PMLiVE

Purdue Pharma files for bankruptcy after opioid settlement

Company has faced brunt of blame for fuelling epidemic

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links